Skip to main content

TMBIM4 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85930

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85930-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the middle region of Human TMBIM4. Peptide sequence: LTVAVVVTFYDVYIILQAFILTTTVFFGLTVYTLQSKKDFSKFGAGLFAL The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for TMBIM4 Antibody

Western Blot: TMBIM4 Antibody [NBP2-85930]

Western Blot: TMBIM4 Antibody [NBP2-85930]

Western Blot: TMBIM4 Antibody [NBP2-85930] - WB Suggested Anti-TMBIM4 Antibody. Titration: 1.0 ug/ml. Positive Control: Placenta

Applications for TMBIM4 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: TMBIM4

Alternate Names

CGI-119, GAAP, LFG4, Protein S1R, S1R, transmembrane BAX inhibitor motif containing 4, transmembrane BAX inhibitor motif-containing protein 4, ZPRO, Z-protein

Gene Symbol

TMBIM4

Additional TMBIM4 Products

Product Documents for TMBIM4 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for TMBIM4 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...